Article Versions Notes

Gianni T, Leoni V, Sanapo M, Parenti F, Bressanin D, Barboni C, Zaghini A, Campadelli-Fiume G, Vannini A. Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV. Viruses. 2021; 13(9):1747. https://doi.org/10.3390/v13091747

Gianni, Tatiana, Valerio Leoni, Mara Sanapo, Federico Parenti, Daniela Bressanin, Catia Barboni, Anna Zaghini, Gabriella Campadelli-Fiume, and Andrea Vannini. 2021. "Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV" Viruses 13, no. 9: 1747. https://doi.org/10.3390/v13091747

Gianni, T., Leoni, V., Sanapo, M., Parenti, F., Bressanin, D., Barboni, C., Zaghini, A., Campadelli-Fiume, G., & Vannini, A. (2021). Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV. Viruses, 13(9), 1747. https://doi.org/10.3390/v13091747